Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment-Reference-Cited by-同舟云学术

Emergency department implementation of monoclonal antibody infusion for the treatment of coronavirus disease 2019: A template for rapid deployment

Published:2021-09-17 Issue:5 Volume:2 Page:
ISSN:2688-1152
Container-title:Journal of the American College of Emergency Physicians Open
language:en
Short-container-title:Journal of the American College of Emergency Physicians Open

Author:

Woltemate Thomas J.¹^ORCID,Wadas Richard J.¹,McCreary Erin K.²,Bariola Ryan²,Minnier Tami³,Marroquin Oscar C.⁴,Schmidhofer Mark⁵,Albin Debbie⁶,Angus Derek C.⁷⁸⁹,Yealy Donald M.¹

Affiliation:

1. Department of Emergency Medicine University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

2. Division of Infectious Diseases, Department of Internal Medicine University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

3. Wolff Center, University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA

4. Clinical Analytics, University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA

5. Division of Cardiology, Department of Medicine University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

6. University of Pittsburgh Medical Center Supply Chain Management/HC Pharmacy University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA

7. Clinical Research Investigation and Systems Modeling of Acute Illness Center, Department of Critical Care Medicine University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

8. University of Pittsburgh Medical Center Health System Office of Healthcare Innovation University of Pittsburgh Medical Center Pittsburgh Pennsylvania USA

9. Department of Critical Care Medicine University of Pittsburgh School of Medicine Pittsburgh Pennsylvania USA

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/emp2.12550

Reference4 articles.

1. Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection

2. Bamlanivimab plus etesevimab in mild or moderate covid‐19;Dougan M;N Engl J Med,2021

3. Establishing a Distribution Network for COVID-19 Monoclonal Antibody Therapy Across a Large Health System During a Global Pandemic

4. Optimizing the Trade-off Between Learning and Doing in a Pandemic

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Our “Side Hustle”;Clinical Infectious Diseases;2023-10-04

2. Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy;Annals of Internal Medicine;2022-12

3. “All of the things to everyone everywhere”: A mixed methods analysis of community perspectives on equitable access to monoclonal antibody treatment for COVID-19;PLOS ONE;2022-11-23

4. “All of the things to everyone everywhere”: A mixed methods analysis of community perspectives on equitable access to monoclonal antibody treatment for COVID-19;2022-08-23

5. More Accessible COVID-19 Treatment Through Monoclonal Antibody Infusion in the Emergency Department;Western Journal of Emergency Medicine;2022-08-19